Pre-solicitationPosted Jul 22, 2026·Responses due Aug 7, 2026

E-Control Systems

CDC · CDC OFFICE OF ACQUISITION SERVICES

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
811210
Value
Not stated
Solicitation
75D30126Q79114
Set-aside
No Set aside used
PSC
J066
Place
Atlanta, GA, USA
Contact
Cole Mullis (ttu3@cdc.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75D30126Q79114 in this department, oldest first.

Early notice
  • Jul 22, 2026 · this notice
    Pre-solicitation
Solicitation
None posted
Award
Not yet. Too few past cases at this agency to estimate timing (2 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

This is a notice of intent to sole source to E-Control Systems for purchase, installation, and calibration of IntelliSense ZB Hardware. CDC�s Mycotic Diseases Branch (MDB) works to determine the burden of fungal infections, respond to outbreaks, and address related public health challenges. To fulfill this mission, MDB relies on state-of-the-art laboratory equipment that must remain fully operational and compliant with Clinical Laboratory Improvement Amendments (CLIA) regulations and International Organization for Standardization (ISO) requirements. These standards mandate continuous monitorin… (show all)

g of temperature and humidity in laboratory areas where quality assurance materials and samples are produced, stored, or tested. Accurate environmental monitoring is critical to ensuring the integrity of laboratory materials and processes. Currently, temperature and humidity are tracked manually, with more than half of the laboratory�s equipment requiring at least daily checks. This approach is inefficient, costly, and increases the risk of undetected environmental fluctuations. The absence of automated alerts when conditions fall outside acceptable ranges further heightens the risk of compromised specimens and noncompliance. To address these challenges, MDB has an urgent need for a robust, automated temperature and humidity monitoring and notification system to maintain quality standards and ensure ongoing regulatory compliance. The purpose of this acquisition is to procure and implement a comprehensive, automated temperature and humidity monitoring and notification system for the CDC�s Mycotic Diseases Branch (MDB) laboratories. This initiative will support MDB�s mission to ensure the quality, integrity, and regulatory compliance of laboratory operations related to fungal disease surveillance, outbreak response, and public health research. This project involves collaboration among MDB laboratory personnel, CDC information technology and facilities teams, and the selected contractor. The contractor will be responsible for providing, installing, integrating, and fully operationalizing a monitoring system capable of continuous environmental surveillance across all designated laboratory areas. The overall objective is to replace manual monitoring processes with a reliable, automated system that continuously records temperature and humidity levels, provides real-time alerts when conditions fall outside established thresholds, and integrates with existing CDC software to generate reports required for compliance. Performance objectives include: Continuous, accurate monitoring and recording of temperature and humidity in all required laboratory spaces Automated notifications to laboratory staff when environmental conditions exceed acceptable ranges Integration with existing CDC systems to support automated reporting and audit readiness for CLIA compliance Secure data storage and retrieval capabilities to maintain complete environmental records High system reliability with minimal downtime and an intuitive user interface Operating constraints include compliance with federal IT security requirements, compatibility with existing CDC infrastructure and software platforms, minimal disruption to laboratory operations during installation and deployment, and adherence to all applicable regulatory and safety standards. The anticipated outcome is a fully compliant, automated monitoring system that improves operational efficiency, reduces the risk of environmental excursions, safeguards laboratory specimens and materials, and ensures sustained compliance with CLIA and ISO requirements. The required monitoring system must integrate with the existing E-Control Systems environmental monitoring infrastructure currently deployed within CDC�s Mycotic Diseases Branch laboratories. The system currently monitors critical laboratory environments including refrigerators, freezers, incubators, ambient room temperature, and humidity conditions that support CLIA-regulated laboratory operations. E-Control Systems has certified that its IntelliSense�, IntelliGate�, and FusionLive� systems are proprietary technologies designed and manufactured exclusively by E-Control Systems. The company further states: No third-party manufacturer or distributor is authorized to replicate or provide equivalent systems, all components are specifically designed to operate within the E-Control Systems ecosystem and are not interchangeable with non-ECS products, any modifications, integrations, or expansions must be performed or approved by E-Control Systems, and calibration and maintenance must be performed directly by E-Control Systems employees. The Government requires full compatibility and integration with the currently installed system to maintain uninterrupted environmental monitoring, data integrity, automated alerting, and compliance with CLIA and ISO requirements. Use of non-ECS products or services would risk incompatibility, operational disruption, and loss of regulatory compliance.

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same office (CDC OFFICE OF ACQUISITION SERVICES), same product/service code (PSC) J066 and NAICS 811210.

Single-winner award sizes (3): middle half $15K to $45K, median $17K; range $14K to $73K.

WinnerAwardsValueLast
ILLUMINA, INC. · $ILMN · $4.5B1$73KJul 6, 2026
COMPUCOM, INC.1$17KJan 20, 2026
Bruker Scientific LLC · $BRKR · $3.0B1$14KJul 6, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $ILMN reported $4.5B revenue in FY2025. The median single-winner award in these 3 past awards, $17K, is under 0.1% of that. 10-K
  • $BRKR reported $3.0B revenue in FY2025. The median single-winner award in these 3 past awards, $17K, is under 0.1% of that. 10-K

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (0 filings)
  • 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 2 of the past winners are listed companies
  • 0 insider buys and 4 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.